News

MPs suggest Government treats councils’ financial woes as ‘normalised noise’
A report by the Public Accounts Committee highlighted perceived flaws or a lack of urgency in the Government’s approach to ...
Vistagen targets transformative SAD drug approval with top-line PALISADE-3 data in Q4 2025 while advancing differentiated neuroscience pipeline
Q4 2025 Management View President and CEO Shawn K. Singh highlighted that Vistagen is advancing a pipeline of five ...